- Home
- CMCL vs AMRN Comparison
CMCL vs AMRN Comparison
Compare CMCL & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCL | AMRN |
|---|---|---|
| Founded | 1992 | 1989 |
| Country | Jersey | Ireland |
| Employees | 2357 | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.3M | 287.9M |
| IPO Year | 2003 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CMCL | AMRN |
|---|---|---|
| Price | $24.19 | $13.44 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $28.00 | $12.00 |
| AVG Volume (30 Days) | ★ 142.6K | 79.0K |
| Earning Date | 05-11-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $38.54 | N/A |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $15.85 | $12.96 |
| 52 Week High | $38.75 | $20.90 |
Technical Indicators
Market Signals| Indicator | CMCL | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 38.27 |
| Support Level | $22.62 | N/A |
| Resistance Level | $24.19 | $14.50 |
| Average True Range (ATR) | 0.97 | 0.39 |
| MACD | -0.40 | -0.03 |
| Stochastic Oscillator | 16.31 | 19.09 |
Price Performance
Historical ComparisonAbout CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. Its project includes Maligreen and Motapa.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.